APA (7th ed.) Citation

Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncology, 8(3), 226. https://doi.org/10.1016/S1470-2045(07)70039-6

Chicago Style (17th ed.) Citation

Gebski, Val, Bryan Burmeister, B Mark Smithers, Kerwyn Foo, John Zalcberg, and John Simes. "Survival Benefits from Neoadjuvant Chemoradiotherapy or Chemotherapy in Oesophageal Carcinoma: A Meta-analysis." Lancet Oncology 8, no. 3 (2007): 226. https://doi.org/10.1016/S1470-2045(07)70039-6.

MLA (9th ed.) Citation

Gebski, Val, et al. "Survival Benefits from Neoadjuvant Chemoradiotherapy or Chemotherapy in Oesophageal Carcinoma: A Meta-analysis." Lancet Oncology, vol. 8, no. 3, 2007, p. 226, https://doi.org/10.1016/S1470-2045(07)70039-6.